Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-64333
Seleznik, Gitta M; Reding, Theresia; Romrig, Franziska; Saito, Yasuyuki; Mildner, Alexander; Segerer, Stephan; Sun, Li-Kang; Regenass, Stephan; Lech, Maciej; Anders, Hans-Joachim; McHugh, Donal; Kumagi, Teru; Hiasa, Yoichi; Lackner, Carolin; Haybaeck, Johannes; Angst, Eliane; Perren, Aurel; Balmer, Maria Luisa; Slack, Emma; Macpherson, Andrew; Manz, Markus; Weber, Achim; Browning, Jeffrey L; Arkan, Melek Canan; Rülicke, Thomas; Aguzzi, Adriano; Prinz, Marco; Graf, Rolf; Heikenwalder, Mathias (2012). Lymphotoxin β receptor signaling promotes development of autoimmune pancreatitis. Gastroenterology, 143(5):1361-1374.
BACKGROUND & AIMS:: Little is known about the pathogenic mechanisms of autoimmune pancreatitis (AIP), an increasingly recognized, immune-mediated form of chronic pancreatitis. Current treatment options are limited and disease relapse is frequent. We investigated factors that contribute to development of AIP and new therapeutic strategies. METHODS:: We used quantitative PCR, immunohistochemical and ELISA analyses to measure expression of cytokines and chemokines in tissue and serum samples from patients with and without AIP. We created a mouse model of human AIP by overexpressing LTα and β specifically in acinar cells ( Ela1-LTab mice). RESULTS:: mRNA levels of lymphotoxin (LT) αandβ were increased in pancreatic tissues from patients with AIP, compared with controls, and expression of chemokines ( CXCL13, CCL19, CCL21, CCL1 and BAFF) was increased in pancreatic and serum samples from patients. Upregulation of these factors was not affected by corticosteroid treatment. Acinar-specific overexpression of LTαβ (Ela1-LTαβ) in mice led to an autoimmune disorder with various features of AIP. Chronic inflammation developed only in the pancreas but was sufficient to cause systemic autoimmunity. Acinar-specific overexpression of LTαβ did not cause autoimmunity in mice without lymphocytes(Ela1-LTab/Rag1(-/-)); moreover lack of pro-inflammatory monocytes (Ela1-LTab/Ccr2-/-) failed to prevent AIP but prevented early pancreatic tissue damage. Administration of corticosteroids reduced pancreatitis but did not affect production of autoantibodies, such as anti-pancreatic secretory trypsin inhibitor in Ela1-LTab mice. In contrast, inhibition of LTβR signaling reduced chemokine expression, renal immune-complex deposition, and features of AIP in Ela1-LTab mice. CONCLUSIONS:: Overexpression of LT α βspecifically in acinar cells of mice causes features of AIP. Reagents that neutralize LT β R ligands might be used to treat patients with AIP.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Hematology|
04 Faculty of Medicine > University Hospital Zurich > Clinic for Immunology
04 Faculty of Medicine > University Hospital Zurich > Institute of Surgical Pathology
04 Faculty of Medicine > University Hospital Zurich > Institute of Neuropathology
04 Faculty of Medicine > University Hospital Zurich > Clinic for Visceral and Transplantation Surgery
|DDC:||570 Life sciences; biology|
610 Medicine & health
|Deposited On:||23 Aug 2012 14:18|
|Last Modified:||28 Feb 2013 22:30|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page